AstraZeneca has secured a preliminary injunction against Glenmark's generic version of diabetes drug dapagliflozin in the UK. The Court of Appeal overturned a first-instance decision that had
Aug 14 (Reuters) - AstraZeneca (AZN.L) on Wednesday convinced a federal judge in Delaware to throw out a jury's decision that the company owes $107.5 million for infringing cancer-drug patents
In the dispute between AstraZeneca and generics manufacturers Viatris, Teva and Glenmark, the UK Court of Appeal has upheld a High Court decision invalidating AstraZeneca's patent, agreeing with the
total 1 pages, 3 items